Bluesight
PrivateLast Round
Private Equity
Jul 17, 2023
Total Funding Raised
$37.4M
Momentum Score
25 /100
Company Overview
Bluesight is a healthcare technology company that provides a hospital inventory management platform designed to offer automated hospital pharmacy kit processing and medication tracking.
Sector
Healthcare & Life Sciences
Verticals
Compliance & Risk, Healthcare Analytics, Pharma Supply Chain, Vertical SaaS, Medical AI
Business Model
B2B
Customer Profile
Subscription SaaS, Hardware + Subscription, Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bluesight Comps
Public and private peers based on sector, stage, and business model.
Bluesight Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Equity | Jul 17, 2023 | ||||
| Series C | Jun 20, 2016 | ||||
| Series B | Jan 12, 2015 | ||||
| Series A | Jul 16, 2013 |
Key People
Founding team and executive leadership
Bluesight Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Leaf Venture Partners | Series C, Series B, Series A |
| Monroe Capital | Private Equity |
| Kaiser Permanente Ventures | Series C, Series B |
| Baxter Ventures | Series C |
| Easton-Hunt Capital Partners, L.P. | Series A, Series C, Series B |
| Black Granite Capital | Series C |
| LionBird | Series A, Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 3, 2026
Integrating GraphiteRx data, including Mark Cuban Cost Plus Drugs, into CostCheck and ShortageCheck.
- Feb 12, 2026
PrivacyPro solution named Best-in-KLAS six times for patient privacy monitoring.
Bluesight Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Bluesight's valuation, stock price, and market status.
